This is a citizen science site -- you can contribute by investing and sharing your time.
Common knowledge amoung some professionals (MD and ND):
Probiotics: Probiotics may aid in managing symptoms associated with IBS, which can commonly co-occur with ME/CFS. While research on the relationship between the gut microbiome and ME/CFS is ongoing, certain probiotics might help alleviate gastrointestinal symptoms such as bloating, gas, and irregular bowel movements.
Omega-3 Fatty Acids: Omega-3 fatty acids from fish oil or certain foods might have anti-inflammatory properties that could potentially benefit individuals with ME/CFS and IBS, especially in managing inflammation and supporting overall health.
Vitamin D: Some individuals with ME/CFS might have lower levels of vitamin D. Maintaining adequate vitamin D levels is important for overall health and immune function. However, supplementation should be guided by healthcare professionals based on individual levels.
Magnesium: Magnesium is involved in various bodily functions, including muscle and nerve function. Some people find that magnesium supplements can help with symptoms like muscle cramps and sleep disturbances, which can be present in ME/CFS.
B Vitamins: B vitamins play essential roles in energy production and nerve function. Some individuals with ME/CFS might benefit from B-complex supplements, although individual responses can vary.
L-Glutamine: L-Glutamine, an amino acid, is sometimes used to support gastrointestinal health and the integrity of the intestinal lining. It might potentially aid in managing symptoms associated with IBS.
The Studies below identify bacteria. Check if it has already been reviewed.
| 1 | 📚 |
Correction to: Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons.
Journal of translational medicine (J Transl Med ) Vol: 16 Issue: 1 Pages: 39 Pub: 2018 Feb 23 ePub: 2018 Feb 23 Authors Wallis A,Ball M,Butt H,Lewis DP,McKechnie S,Paull P,Jaa-Kwee A,Bruck D |
| 2 | 📚 |
Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Microbiome (Microbiome ) Vol: 5 Issue: 1 Pages: 44 Pub: 2017 Apr 26 ePub: 2017 Apr 26 Authors Nagy-Szakal D,Williams BL,Mishra N,Che X,Lee B,Bateman L,Klimas NG,Komaroff AL,Levine S,Montoya JG,Peterson DL,Ramanan D,Jain K,Eddy ML,Hornig M,Lipkin WI |
| 3 | 📚 |
High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients.
Anaerobe (Anaerobe ) Vol: 22 Issue: Pages: 50-6 Pub: 2013 Aug ePub: 2013 Jun 19 Authors Frémont M,Coomans D,Massart S,De Meirleir K |
| 4 | 📚 |
Increased d-lactic Acid intestinal bacteria in patients with chronic fatigue syndrome.
In vivo (Athens, Greece) (In Vivo ) Vol: 23 Issue: 4 Pages: 621-8 Pub: 2009 Jul-Aug ePub: Authors Sheedy JR,Wettenhall RE,Scanlon D,Gooley PR,Lewis DP,McGregor N,Stapleton DI,Butt HL,DE Meirleir KL |
The Studies below identify substances that has been tried with positive changes (for at least some symptoms in the study). Check if it has already been reviewed.
| 5 | 📚 |
Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial.
Nutrients (Nutrients ) Vol: 12 Issue: 2 Pages: Pub: 2020 Jan 30 ePub: 2020 Jan 30 Authors Martoni CJ,Srivastava S,Leyer GJ |
The following items have been cited in the above studies
| ID | Studies | Name | AKA |
|---|---|---|---|
| 46 | 1 | Bifidobacterium animalis subsp. lactis {B. Lactis} | Includes BB-12, DN-173 010 ,Bifidobacterium Regularis,Bifidus Regularis |
| 230 | 1 | lactobacillus acidophilus {L. acidophilus} | Bacillus acidophilus |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
